scispace - formally typeset
J

Jo Vandesompele

Researcher at Ghent University

Publications -  406
Citations -  67052

Jo Vandesompele is an academic researcher from Ghent University. The author has contributed to research in topics: Neuroblastoma & microRNA. The author has an hindex of 88, co-authored 383 publications receiving 59368 citations. Previous affiliations of Jo Vandesompele include Washington University in St. Louis & Ghent University Hospital.

Papers
More filters
Journal ArticleDOI

Asthma inflammatory phenotypes show differential microRNA expression in sputum

TL;DR: Expression of miR-629-3p, mi-223-3P, and mi-142-3 p is increased in sputum of patients with severe asthma and is linked to neutrophilic airway inflammation, suggesting that these miRNAs contribute to this asthma inflammatory phenotype.
Journal ArticleDOI

Single-Nucleotide Polymorphisms and Other Mismatches Reduce Performance of Quantitative PCR Assays

TL;DR: Single mismatches located >5 bp from the 3' end have a moderate effect on qPCR amplification and can be tolerated, and this finding, together with the concentration independence for single mismatches and the complete blocking of the PCR reaction for ≥4 mismatches, can help to chart mismatch behavior inqPCR reactions and increase the rate of successful primer design for sequences with a high SNP density or for homologous regions of sequence.
Book ChapterDOI

miRNA expression profiling: from reference genes to global mean normalization.

TL;DR: The power of the previously described global meannormalization method is summarized in comparison to the multiple reference gene normalization method using the most stably expressed small RNA controls and a modified global mean normalization strategy based on the attribution of equal weight to each individual miRNA during normalization is compared.
Journal ArticleDOI

Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes

TL;DR: This unique dataset adds power to ongoing and future gene expression studies in neuroblastoma and will facilitate the identification of molecular targets for novel therapies and could prove useful for the further study of human sympathoadrenal biogenesis.